Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
286
-
Total 13F shares, excl. options
-
44.7M
-
Shares change
-
+313K
-
Total reported value, excl. options
-
$2.82B
-
Value change
-
-$43.7M
-
Put/Call ratio
-
1.31
-
Number of buys
-
138
-
Number of sells
-
-183
-
Price
-
$62.99
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2021
375 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q2 2021.
Emergent BioSolutions Inc. - Common Stock (EBS) has 286 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.7M shares
of 54.5M outstanding shares and own 82.11% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.84M shares), VANGUARD GROUP INC (4.96M shares), JANUS HENDERSON GROUP PLC (3.65M shares), Neuberger Berman Group LLC (3.4M shares), STATE STREET CORP (2.13M shares), EARNEST PARTNERS LLC (2.12M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.35M shares), DIMENSIONAL FUND ADVISORS LP (976K shares), NORTHERN TRUST CORP (941K shares), and GEODE CAPITAL MANAGEMENT, LLC (843K shares).
This table shows the top 286 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.